Exelixis (EXEL) stock Forecast for 2021 – 2025

Exelixis (EXEL) stock Forecast for 2022 – 2026

Last update: November 27, 2022 (05:58)

Sector: Healthcare

The share price of Exelixis, Inc. (EXEL) now

What analysts predict: $26.53

52-week high/low: $23.4 / $14.87

50/200 Day Moving Average: $16.41 / $19.41

This figure corresponds to the average price over the previous 50/200 days. For Exelixis stocks, the 50-day moving average is the support level today.

For Exelixis stocks, the 200-day moving average is the resistance level today.

Are you interested in Exelixis, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Exelixis stock price in 2022, 2023, 2024, 2025, 2026. How much will one Exelixis share be worth in 2022 - 2026?

When should I take profit in Exelixis stock? When should I record a loss on Exelixis stock? What are analysts' forecasts for Exelixis stock? What is the future of Exelixis stock? We forecast Exelixis stock performance using neural networks based on historical data on Exelixis stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Exelixis stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Exelixis shares. This happens once a day.




Historical and forecast chart of Exelixis stock

The chart below shows the historical price of Exelixis stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Exelixis stock price can be found in the table below.

Long-term forecasts by years.

Exelixis daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 29 16.74 16.32 17.16 5.21
Nov 30 17.01 16.70 17.16 2.75
Dec 01 16.81 16.66 17.12 2.75
Dec 02 16.47 16.23 16.69 2.88
Dec 03 16.22 15.97 16.41 2.77
Dec 04 16.24 16.04 16.48 2.73
Dec 05 16.12 15.97 16.30 2.05
Dec 06 15.88 15.59 16.13 3.46
Dec 07 15.54 15.40 15.88 3.11
Dec 08 15.39 15.02 15.50 3.16
Dec 09 15.51 15.14 15.86 4.77
Dec 10 15.42 15.24 15.57 2.16
Dec 11 15.60 15.46 15.73 1.77
Dec 12 15.62 15.18 15.99 5.37
Dec 13 15.37 15.02 15.57 3.72
Dec 14 15.11 14.92 15.22 2.02
Dec 15 15.39 15.05 15.73 4.51
Dec 16 15.52 15.20 15.90 4.61
Dec 17 15.03 14.61 15.20 4.03
Dec 18 14.91 14.61 15.22 4.22
Dec 19 14.94 14.74 15.36 4.22
Dec 20 14.46 14.29 14.84 3.79
Dec 21 14.91 14.78 15.08 2.05
Dec 22 15.43 15.12 15.63 3.39
Dec 23 15.17 14.97 15.35 2.55
Dec 24 15.36 15.08 15.77 4.56
Dec 25 15.57 15.26 15.99 4.79
Dec 26 15.07 14.83 15.27 2.99
Dec 27 14.73 14.52 14.95 2.95
Dec 28 14.24 14.03 14.44 2.91

Exelixis Daily Price Targets


Exelixis Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $16.74.
Negative dynamics for Exelixis shares will prevail with possible volatility of 4.950%.
Pessimistic target level: 16.32
Optimistic target level: 17.16

Exelixis Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $17.01.
Positive dynamics for Exelixis shares will prevail with possible volatility of 2.672%.
Pessimistic target level: 16.70
Optimistic target level: 17.16

Exelixis Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $16.81.
Negative dynamics for Exelixis shares will prevail with possible volatility of 2.681%.
Pessimistic target level: 16.66
Optimistic target level: 17.12

Exelixis Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $16.47.
Negative dynamics for Exelixis shares will prevail with possible volatility of 2.798%.
Pessimistic target level: 16.23
Optimistic target level: 16.69

Exelixis Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $16.22.
Negative dynamics for Exelixis shares will prevail with possible volatility of 2.697%.
Pessimistic target level: 15.97
Optimistic target level: 16.41

Exelixis Stock Forecast 12-04-2022.

Forecast target price for 12-04-2022: $16.24.
Positive dynamics for Exelixis shares will prevail with possible volatility of 2.655%.
Pessimistic target level: 16.04
Optimistic target level: 16.48

EXEL (EXEL) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 17.85 17.50 18.40 4.89

Exelixis forecast for this year


Exelixis Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $17.8536. Pessimistic: $17.50. Optimistic: $18.40



Exelixis (EXEL) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 17.08 16.48 17.47 5.63
Feb 16.68 16.37 17.58 6.92
Mar 17.06 16.44 17.53 6.22
Apr 15.55 14.62 16.60 11.97
May 16.45 15.59 17.32 10.00
Jun 16.54 15.70 17.64 10.97
Jul 16.18 15.54 16.78 7.38
Aug 16.06 15.62 17.22 9.32
Sep 15.52 14.58 16.00 8.90
Oct 15.70 15.29 16.54 7.60
Nov 16.11 15.25 16.98 10.16
Dec 17.22 16.42 17.67 7.10

Exelixis (EXEL) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 16.66 15.72 17.19 8.55
Feb 17.28 16.10 18.07 10.93
Mar 17.65 16.78 18.34 8.49
Apr 18.42 17.84 19.01 6.19
May 18.80 17.44 19.20 9.16
Jun 20.49 19.46 21.83 10.89
Jul 20.52 19.99 21.58 7.36
Aug 18.86 17.83 19.80 9.95
Sep 18.86 18.10 19.71 8.18
Oct 18.91 18.06 19.88 9.16
Nov 19.27 18.11 20.00 9.45
Dec 20.99 20.19 22.23 9.17

Exelixis (EXEL) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 20.16 19.09 20.56 7.15
Feb 19.99 19.13 21.02 8.99
Mar 19.02 18.44 19.48 5.36
Apr 19.79 18.95 21.15 10.36
May 20.65 20.20 21.50 6.05
Jun 21.00 20.58 21.38 3.71
Jul 22.02 21.15 22.79 7.22
Aug 23.78 22.99 24.79 7.25
Sep 23.19 21.68 24.02 9.73
Oct 25.25 23.48 26.27 10.64
Nov 26.32 25.80 28.14 8.33
Dec 26.56 25.70 27.49 6.52

Exelixis (EXEL) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 25.55 24.45 26.29 7.00
Feb 27.23 26.18 28.65 8.64
Mar 24.95 23.87 26.70 10.60
Apr 24.73 23.39 25.64 8.77
May 23.99 23.39 24.58 4.83
Jun 23.65 22.03 24.26 9.21
Jul 22.84 21.54 23.80 9.50
Aug 24.69 23.89 25.24 5.37
Sep 24.18 23.22 24.92 6.81
Oct 26.24 24.78 27.50 9.88
Nov 27.52 26.88 29.40 8.59
Dec 28.31 26.40 28.90 8.64

Exelixis information and performance

Exelixis, Inc. is a biotechnology company specializing in the development of promising low molecular weight drugs for the treatment of cancer and other serious diseases, including kidney damage, thyroid cancer and progressive melanoma. In addition, the company is forging strategic partnerships with other pharmaceutical and biotech companies.

Official site of the company

Exelixis Address

1851 HARBOR BAY PARKWAY, ALAMEDA, CA, US

Market Capitalization: 5 454 506 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 383 066 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 17.8

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.339

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.95

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.894
Quarterly Revenue Growth YOY: 0.254
Trailing PE: 17.8

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 11.35

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.485

Enterprise Value (EV) /Revenue

EV To EBITDA: 10.63

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 322561000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.